Larisma, Carmelita G.
HRN: 05-93-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/24/2022
12/01/2022
IV
1.5gms
Q6
T/C Acute Uncomplicated Cholecystitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes